At a glance
ClinicalIndex Comparison RecordN/ACompleted· 409 enrolled
Drug / intervention
AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0] +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2
In Brief
A clinical study evaluating AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0] and AcrySof® IQ Monofocal IOL Model SN60WF for Cataracts. Completed, enrolled 409 participants.
Detailed Summary
The purpose of this study is to compare the safety and efficacy of an investigational multifocal intraocular lens (IOL) to an FDA-approved monofocal IOL.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataracts
Countries--
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 2012
Enrollment StartFeb 2012
Primary CompletionDec 2012
TodayJul 2026
First PostedJan 16, 2012
Enrollment StartFeb 1, 2012
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 14.5 years ago
Interventions
AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]device
Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient
AcrySof® IQ Monofocal IOL Model SN60WFdevice
Monofocal IOL implanted for long-term use over the lifetime of the cataract patient